Background: Supraventricular tachycardia (SVT) is the most common arrhythmia requiring treatment in neonates, but there are no published evidence-based guidelines for management in neonatal units.
Background: Physiological instability is common during endotracheal intubation; neonates are particularly vulnerable to deterioration. Nasal high flow (nHF) use during laryngoscopy and intubation (THRIVE-Transnasal Humidified Rapid Insufflation Ventilatory Exchange) may limit oxygen desaturation. This systematic review evaluated the efficacy of nHF in improving oxygenation during paediatric anaesthesia or endotracheal intubation.
Methods: This systematic review was conducted in accordance with Cochrane methodology. Studies were identified by searching electronic databases (Pubmed, Scopus). The primary outcome was oxygenation, defined as safe apnoeic time or desaturation. Secondary outcomes included bradycardia, successful intubation and air leak.
Results: Two randomised controlled trials (RCTs) were identified for inclusion (n = 108 patients); both evaluated THRIVE during paediatric general anaesthesia. Humphreys et al. (2017) randomised 48 patients to THRIVE (age-specific flow rates), or to jaw support alone. Riva et al. (2018) randomised 60 patients to low-flow oxygen (0.2 L/kg/min), THRIVE 100% oxygen or THRIVE 30% oxygen (flow 2 L/kg/min). Humphreys demonstrated a significantly longer apnoea time in patients receiving THRIVE (192 s in 0-6 month age group, p < 0.001), compared with standard care. Riva showed no significant difference in apnoea time between THRIVE 100% oxygen and low-flow groups, however the primary outcome (oxygen saturation < 95%) was not reached for any patient.
Conclusions: Nasal HF use may extend the safe apnoeic time in children with healthy lungs undergoing general anaesthesia. The technique has not been assessed in emergency paediatric intubations, or in neonates. Randomised trials of nHF use during neonatal intubation are required to assess the efficacy of the technique in this population. Vasa praevia has been one of the causes of stillbirth and neonatal death for many years. However, little is known about the impact of these events on the maternity care providers. This study aimed to explore the experience of midwives and obstetricians who had cared for a woman who experienced adverse perinatal outcomes due to unanticipated vasa praevia.
CARING FOR WOMEN WITH UNANTICIPATED
Methods: A qualitative study was conducted with 42 clinicians (20 midwives and 22 obstetricians) practising in public or private setting across all states and territories of Australia during 2016-2017. Semi-structured in-depth interviews were analysed thematically and inductively.
Results: Caring for women who experienced intrapartum stillbirth or early neonatal death due to vasa praevia had a profound impact on the midwives and obstetricians who were directly involved in these events. Feelings of distress, fear, guilt, blame, and empathy with the families were dominant themes in the narratives. Recognising the ethical and professional responsibility of providing safe maternity care for women and their babies was the driving force to these clinicians to continue practising, learning from these events to prevent future adverse perinatal outcomes.
Conclusions: Clinicians involved in the intrapartum care of women who experience unanticipated adverse perinatal outcomes could be seen as being second 'victims' of the events and need to be provided with support. Perhaps it is time to move from lamenting vasa praevia to the antenatal diagnosis of this condition to improve the safety and quality of maternity care for all women and babies.
